Research suggests that vaccinations against rare strains of bird flu would be highly effective against a broad range of influenza viruses

A Universal Flu Vaccine: Could Rare Flu Strains be the Answer?

Research suggests that vaccinations against rare strains of bird flu would be highly effective against a broad range of influenza viruses A study by the Emory Vaccine Centre in Atlanta has found that exposure to rare and uncommon flu strains results in the production of broadly effective antibodies. The study thus begs the question: should the public be vaccinated against …

Presentation: Preventing zoonotic influenza Infection through continued surveillance of swine and Avian influenza virus

  At the last Influenza Summit Asia, part of World Vaccine Congress Asia 2013, Cissy B. Kartasasmita of Indonesian Influenza Foundation gave the following presentation entitled: Preventing zoonotic influenza Infection through continued surveillance of swine and Avian influenza virus. Download this presentation today! Some of the points covered during the presentation include: Influenza control and surveillance in Indonesia Avian influenza …

GSK’s H5N1 flu vaccine gets green light from FDA

GlaxoSmithKline’s pandemic H5N1 (avian flu) vaccine has been approved by the US FDA for use in the event of an H5N1 avian flu epidemic. The vaccine won’t be available for commercial use, but will be added to the national stockpile for use as directed by BARDA. The vaccine is the first FDA-approved adjuvanted vaccine for H5N1, which kills about 60% …

IDRI and Medicago to present H5N1 vaccine data at the World Vaccine Congress

IDRI (Infectious Disease Research Institute) and Medicago Inc. have announced that they will be presenting positive interim Phase I clinical results of their H5N1 Avian Influenza VLP (Virus-Like Particles) vaccine candidate at the upcoming World Vaccine Congress, Washington DC. In the presentation, titled “H5N1 Phase 1 clinical trial combining Medicago’s VLP vaccine with IDRI’s GLA adjuvant formulation,” Dr Steven Reed, …

Surveillance study of ILI and SARI in East Jakarta

Rita Kusriastuti, Director of Vector Borne Disease Control of Indonesia's Ministry of Health joined us at World Vaccine Congress Asia this year to share the case study on Indonesia's surveillance study of ILI and SARI. The study was conducted in East Jakarta, an area with a population of 2.6 million and high risk potential for avian-to-human H5N1 virus transmission. The …